Sepp-Lorenzino; Laura

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sepp-Lorenzino; Laura.The latest application filed is for "systemic delivery of myostatin short interfering nucleic acids (sina) conjugated to a lipophilic moiety".

Company Profile

10.12.14

Sepp-Lorenzino; Laura - Cambridge MA
Sepp-Lorenzino; Laura - Jenkintown PA
Sepp-Lorenzino; Laura - New Haven CT
Sepp-Lorenzino, Laura - Landsdale PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for the treatment of subjects having a hepatitis b virus (HBV) infection Grant 11,324,820 - Sepp-Lorenzino , et al. May 10, 2	2022-05-10
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof Grant 11,060,091 - Hinkle , et al. July 13, 2	2021-07-13
Myostatin iRNA compositions and methods of use thereof Grant 10,933,081 - Jadhav , et al. March 2, 2	2021-03-02
Systemic Delivery Of Myostatin Short Interfering Nucleic Acids (sina) Conjugated To A Lipophilic Moiety App 20210008226 - Tadin-Strapps; Marija ; et al.	2021-01-14
HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20200291405 - Hinkle; Gregory ; et al.	2020-09-17
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety Grant 10,729,787 - Tadin-strapps , et al.	2020-08-04
HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20200140864 - Hinkle; Gregory ; et al.	2020-05-07
Myostatin Irna Compositions And Methods Of Use Thereof App 20200138847 - Jadhav; Vasant R. ; et al.	2020-05-07
Hepatitis D virus (HDV) iRNA compositions and methods of use thereof Grant 10,640,770 - Hinkle , et al.	2020-05-05
Methods For The Treatment Of Subjects Having A Hepatitis B Virus (hbv) Infection App 20200038506 - Sepp-Lorenzino; Laura ; et al.	2020-02-06
Hepatitis B virus (HBV) iRNA compositions and methods of use thereof Grant 10,513,703 - Hinkle , et al. Dec	2019-12-24
SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (siNA) CONJUGATED TO A LIPOPHILIC MOIETY App 20190060488 - Tadin-strapps; Marija ; et al.	2019-02-28
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety Grant 10,004,814 - Tadin-Strapps , et al. June 26, 2	2018-06-26
HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20170349900 - Hinkle; Gregory ; et al.	2017-12-07
HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF App 20170349901 - Hinkle; Gregory ; et al.	2017-12-07
Methods And Compositions For Inhalation Delivery Of Conjugated Oligonucleotide App 20170304459 - JADHAV; Vasant ; et al.	2017-10-26
SYSTEMIC DELIVERY OF MYOSTATIN SHORT INTERFERING NUCLEIC ACIDS (siNA) CONJUGATED TO A LIPOPHILIC MOIETY App 20160256570 - Tadin-Strapps; Marija ; et al.	2016-09-08
Isolated Nucleic Acid Molecules Corresponding To Micro Rna 145 (mirna-145) And Their Use In Treating Colon Cancer App 20100113577 - Shi; Bin ; et al.	2010-05-06
Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases Grant 7,271,160 - Rosen , et al. September 18, 2	2007-09-18
Methods and compositions for degradation and/or inhibition of HER-family tyrosine kinases Grant 7,238,682 - Rosen , et al. July 3, 2	2007-07-03
Method of treating cancer Grant 6,989,383 - Rosen , et al. January 24, 2	2006-01-24
Method of treating cancer App 20050137207 - Rosen, Neal ; et al.	2005-06-23
Methods and compositions for destruction of selected proteins Grant 6,670,348 - Rosen , et al. December 30, 2	2003-12-30
Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases App 20020045570 - Rosen, Neal ; et al.	2002-04-18

Company Registrations

SEC

0001777421

Sepp-Lorenzino Laura

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.